Yestar Healthcare Holdings Company Limited (HKG:2393)
Hong Kong · Delayed Price · Currency is HKD 0.1170
+0.0040 (3.54%)
Feb 11, 2026, 4:08 PM HKT
HKG:2393 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,939 | 2,410 | 2,913 | 2,805 | 4,931 | 4,107 | |
Revenue Growth (YoY) | -28.56% | -17.26% | 3.86% | -43.12% | 20.06% | -16.24% |
Cost of Revenue | 1,623 | 2,011 | 2,400 | 2,407 | 4,082 | 3,300 |
Gross Profit | 315.3 | 399.2 | 512.78 | 397.55 | 848.7 | 806.88 |
Selling, General & Admin | 300.59 | 362.41 | 380.58 | 364.9 | 657.01 | 623.46 |
Other Operating Expenses | 180.49 | 180.49 | - | - | - | - |
Operating Expenses | 450.55 | 519.06 | 341.74 | 504.38 | 664.33 | 648.74 |
Operating Income | -135.25 | -119.86 | 171.04 | -106.83 | 184.37 | 158.14 |
Interest Expense | -15.44 | -30.16 | -164.71 | -273.14 | -127.79 | -124.08 |
Interest & Investment Income | 1.49 | 1.49 | 2.39 | 4.96 | 8.25 | 11.35 |
Earnings From Equity Investments | - | - | - | - | 7.99 | 5.25 |
Currency Exchange Gain (Loss) | - | - | - | 10.03 | - | 11.43 |
Other Non Operating Income (Expenses) | -1,096 | -5.26 | 7.2 | 2.58 | -7.39 | 17.75 |
EBT Excluding Unusual Items | -1,245 | -153.8 | 15.93 | -362.39 | 65.43 | 79.84 |
Impairment of Goodwill | - | - | - | -1.44 | - | -447.45 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.03 | 0.33 |
Gain (Loss) on Sale of Assets | 0.03 | 0.03 | 0.41 | 0.34 | 0.91 | 17.55 |
Asset Writedown | - | - | - | -121.29 | -41.58 | -342.86 |
Other Unusual Items | 1,083 | 1,083 | 24.71 | - | 35.16 | - |
Pretax Income | -161.53 | 929.64 | 41.04 | -484.78 | 59.94 | -692.6 |
Income Tax Expense | 16.87 | 26.67 | 39.56 | -10.83 | 47.26 | -47.3 |
Earnings From Continuing Operations | -178.4 | 902.98 | 1.48 | -473.95 | 12.68 | -645.3 |
Earnings From Discontinued Operations | - | 0.54 | -4.57 | -531.92 | - | - |
Net Income to Company | -178.4 | 903.51 | -3.09 | -1,006 | 12.68 | -645.3 |
Minority Interest in Earnings | 16.54 | 18.1 | -10.79 | 13.63 | -9.35 | 54.81 |
Net Income | -161.86 | 921.61 | -13.89 | -992.23 | 3.33 | -590.49 |
Net Income to Common | -161.86 | 921.61 | -13.89 | -992.23 | 3.33 | -590.49 |
Shares Outstanding (Basic) | 2,332 | 2,332 | 2,332 | 2,332 | 2,347 | 2,362 |
Shares Outstanding (Diluted) | 2,332 | 2,332 | 2,332 | 2,332 | 2,347 | 2,362 |
Shares Change (YoY) | - | - | - | -0.64% | -0.64% | -1.21% |
EPS (Basic) | -0.07 | 0.40 | -0.01 | -0.43 | 0.00 | -0.25 |
EPS (Diluted) | -0.07 | 0.40 | -0.01 | -0.43 | 0.00 | -0.25 |
Free Cash Flow | 239.65 | -26.45 | 292.54 | -115.58 | 665.55 | 591.92 |
Free Cash Flow Per Share | 0.10 | -0.01 | 0.13 | -0.05 | 0.28 | 0.25 |
Gross Margin | 16.26% | 16.56% | 17.61% | 14.17% | 17.21% | 19.65% |
Operating Margin | -6.98% | -4.97% | 5.87% | -3.81% | 3.74% | 3.85% |
Profit Margin | -8.35% | 38.24% | -0.48% | -35.38% | 0.07% | -14.38% |
Free Cash Flow Margin | 12.36% | -1.10% | 10.04% | -4.12% | 13.50% | 14.41% |
EBITDA | -98.52 | -72.29 | 238.97 | 14.71 | 315.89 | 305.49 |
EBITDA Margin | -5.08% | -3.00% | 8.20% | 0.52% | 6.41% | 7.44% |
D&A For EBITDA | 36.73 | 47.57 | 67.93 | 121.54 | 131.52 | 147.35 |
EBIT | -135.25 | -119.86 | 171.04 | -106.83 | 184.37 | 158.14 |
EBIT Margin | -6.98% | -4.97% | 5.87% | -3.81% | 3.74% | 3.85% |
Effective Tax Rate | - | 2.87% | 96.40% | - | 78.85% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.